PG
OPTR

PEAK6 Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

PEAK6 Group’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-40,000
Closed -$252K – 6008
2013
Q3 		$252K Buy
+40,000
New +$530K ﹤0.01% 3478

PEAK6 Group's OPTR Position: Q4 2013 in Review

PEAK6 Group sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 16,800 shares — an estimated $106K sold.

PEAK6 Group first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $106K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • PEAK6 Group reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • PEAK6 Group sold 16,800 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $106K.
  • PEAK6 Group first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • PEAK6 Group's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $106K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on PEAK6 Group's 13F filing for Q4 2013, filed 13 Feb 2014.